MedPath

Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty

Not Applicable
Completed
Conditions
Osteoarthritis, Hip
Interventions
Drug: Standard of Care
Drug: Multi-modal with as needed opioids
Drug: Multi-modal with one week of opioids offered
Registration Number
NCT03358888
Lead Sponsor
Rothman Institute Orthopaedics
Brief Summary

This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients will still be routinely provided PRN oxycodone and tramadol to use on an as needed basis. The third arm will comprise a multimodal pain management protocol, which does not routinely allow for opioid consumption. However, patients will be provided a one week supply of oxycodone and tramadol for emergency pain relief only.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
228
Inclusion Criteria
  • Patients undergoing unilateral, primary cementless THA with underlying diagnosis of osteoarthritis.
  • ASA I - III
  • Spinal anesthesia
  • Male and Female over 18 who are willing and able to provide informed consent
Exclusion Criteria
  • Opioid use within 3 months prior to surgery
  • General anesthesia
  • Non-english speaking
  • ASA IV or greater
  • Allergy/contraindications to protocol medications
  • Renal insufficiency with Cr > 2.0 or hepatic failure
  • Sensory/motor disorder involving the operative limb
  • Planned or unplanned discharge to rehab
  • Length of stay >3 days
  • Revision or conversion THA
  • Cigarette smokers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard of CareStandard of Care-
Multi-modal with as needed opioidsMulti-modal with as needed opioids-
Multi-modal with one week of opioids offeredMulti-modal with one week of opioids offered-
Primary Outcome Measures
NameTimeMethod
Pain30 days post-operative

Pain as reported by Visual Analog Scale

total opioid consumptiontotal consumption calcuated from surgery date through 30 days post-op
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rothman Institute

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath